CinnaGen Co Unipessoal LDA
2 products tracked · names used in filings: CinnaGen Co Unipessoal LDA
Upcoming milestones
No upcoming milestones listed.
Recent milestones
Mon 27 Apr 2026🇪🇺 EU approval (EC decision)
Zandoriah (teriparatide) approved in the EU
Marketing authorisation to CinnaGen Co Unipessoal LDA; Biosimilar, Additional monitoring · source
Thu 26 Feb 2026🇪🇺 CHMP positive opinion
Zandoriah (teriparatide): CHMP positive opinion
CinnaGen Co Unipessoal LDA; Biosimilar, Additional monitoring · source
Products
| Product | Status | Approved | |
|---|---|---|---|
| 🇪🇺 | Teriparatide Cinnagen teriparatide | Application withdrawn | |
| 🇪🇺 | Zandoriah teriparatide | Authorised | 2026-04-27 |
Information from official EMA, FDA, Federal Register and SEC records. Dates marked company-announced come from the company's own SEC filing; dates marked estimate are calculated, not official. Not investment or medical advice; always confirm on the source.